grant

Longitudinal Study of HIV and Aging in Brazil

Organization VANDERBILT UNIVERSITY MEDICAL CENTERLocation NASHVILLE, UNITED STATESPosted 15 Aug 2021Deadline 30 Apr 2027
NIHUS FederalResearch GrantFY2025(TNF)-α21+ years old65 and older65 or older65 years of age and older65 years of age or more65 years of age or older65+ years65+ years oldAIDS VirusASCVDAcquired Immune Deficiency Syndrome VirusAcquired Immunodeficiency Syndrome VirusAdultAdult HumanAdult T-Cell Leukemia-Lymphoma Virus IAffectAgeAge YearsAged 65 and OverAgingAmerican TrypanosomiasisAmerican trypanosomeAreaAssessment instrumentAssessment toolAtherosclerosisAtherosclerotic Cardiovascular DiseaseAutomobile DrivingBiologicalBiology of AgingBrazilCMVCachectinCanadaCardiometabolic DiseaseCardiometabolic DisorderCaribbeanCaribbean Sea RegionCaribbean regionCaringCentral AmericaCessation of lifeChagas DiseaseChemotactic CytokinesChronicCitiesClinicalClinical ResearchClinical StudyClinical assessmentsCognitive DisturbanceCognitive ImpairmentCognitive declineCognitive function abnormalCollaborationsCountryCytomegalovirusDataDeathDevelopmentDiseaseDisorderDisturbance in cognitionEconomic IncomeEconomical IncomeElderlyElderly AssessmentEpidemicEpidemiologic ResearchEpidemiologic StudiesEpidemiological StudiesEpidemiological dataEpidemiologyEpidemiology ResearchEpidemiology dataEvaluationGeriatric AssessmentGeriatricsGermanyHCMVHHV-8HHV8HIVHIV InfectionsHTLV-1HTLV-IHTLV-III InfectionsHTLV-III-LAV InfectionsHTLV1Health PolicyHistoryHomologous Chemotactic CytokinesHospital AdmissionHospitalizationHuman Herpesvirus 8Human Immunodeficiency VirusesHuman T-Cell Leukemia Virus IHuman T-Lymphotropic Virus Type III InfectionsHuman T-lymphotropic virus 1IQ DeficitImmunochemical ImmunologicImmunologicImmunologicalImmunologicallyImmunologicsImmunologyImpaired cognitionIncomeIndividualInduction of ApoptosisInfectionInflammationInflammatoryInstitutionIntercrinesInvestigatorsIsoformsKSHVKaposi Sarcoma-Associated Herpes VirusKaposi Sarcoma-Associated HerpesvirusKaposi sarcoma associated virusKaposi sarcoma herpes virusKaposi's sarcoma (KS)-associated herpesvirusKnowledgeLAV-HTLV-IIILMICLaboratoriesLatin AmericaLife ExpectancyLigandsLinkLong-Term EffectsLong-term infectionLongitudinal StudiesLymphadenopathy-Associated VirusLymphatic cellLymphocyteLymphocyticM tuberculosis infectionM. tb infectionM. tuberculosis infectionM.tb infectionM.tuberculosis infectionMTB infectionMacrophageMacrophage-Derived TNFMeasuresMediatingMedical EconomicsMonocyte-Derived TNFMorbidityMorbidity - disease rateMycobacterium tuberculosis (MTB) infectionMycobacterium tuberculosis infectionNational Institutes of HealthNeurocognitive DeficitObservation in researchOlder PopulationOnset of illnessOutcomePathogenesisPathway interactionsPersonsPositionPositioning AttributePredicting RiskProductivityProtein IsoformsQOLQuality of lifeRecording of previous eventsResearchResearch PersonnelResearch ResourcesResearchersResourcesRisk FactorsSIS cytokinesSalivary Gland VirusesScreening procedureSocioeconomic FactorsSourceSouth AmericaSouth American TrypanosomiasisStandardizationSyndromeT cruziT gondii infectionT. cruziT. gondii infectionTB infectionTNFTNF ATNF AlphaTNF geneTNF-αTNFATNFαTelomere ShorteningToxoplasma gondii InfectionToxoplasmosisTranslational ResearchTranslational ScienceTrypanosoma cruziTuberculosisTumor Necrosis FactorTumor Necrosis Factor-alphaType I Human T-Lymphotropic VirusUnited StatesUnited States National Institutes of HealthValidationViralVirus-HHV8Virus-HIVVirus-HTLV-IWest Indies Regionabove age 65adulthoodadvanced ageafter age 65age 65 and greaterage 65 and olderage 65 or olderageage of 65 years onwardage related pathwaysaged 65 and greateraged 65+aged ≥65agesaging associatedaging associated diseaseaging associated disordersaging associated mechanismaging mechanismaging morbidityaging pathwayaging relatedaging related diseaseaging related disordersaging related mechanismaging related pathwaysantiretroviral therapyantiretroviral treatmentatheromatosisatherosclerotic diseaseatherosclerotic vascular diseasebehavioral economicsbiologicbiological mechanism of agebiological pathways of ageburden of infectionchemoattractant cytokinechemokinechronic infectionclinical predictorsco-infectionco-morbidco-morbiditycognitive dysfunctioncognitive losscoinfectioncomorbiditycytokinecytomegalovirus groupdecline in functiondecline in functional statusdevelopmentaldisabilitydisease associated with agingdisease of agingdisease onsetdisorder of agingdisorder onsetdisorders associated with agingdisorders related to agingdisseminated TBdisseminated tuberculosisdrivingearly onseteffective therapyeffective treatmentepidemiologicepidemiologic dataepidemiologic investigationepidemiologicalepidemiology studyexperiencefallsforecasting riskfrailtyfunctional declinefunctional status declinegeriatricgeriatric medicinegeriatric screeninghealth care policyhistorieshuman T cell lymphoma virus Ihuman T cell lymphoma virus type Ihuman T cell lymphotropic virus 1human T cell lymphotropic virus type 1human T lymphotropic virus Ihuman T-cell leukemia virus type 1human old age (65+)improvedincomesinfection burdeninfection due to Mycobacterium tuberculosisinflammation markerinflammatory markerinsightintelligence quotient deficitkaposi's sarcoma herpesviruskaposi's sarcoma-associated human herpesviruslong-term studylongitudinal outcome studieslow and middle-income countrieslymph cellmalleable riskmechanism regulating agingmechanisms involved in agingmitochondrial dysfunctionmodifiable riskmycobacterialneurocognitive declineneurocognitive impairmentnovelold ageolder adultolder adulthoodolder groupsolder individualsolder personover 65 yearspathogenpathwaypathway involved in agingpersistent infectionpredict riskpredict riskspredicted riskpredicted riskspredicting riskspredictive riskpredicts riskprospectivepublic health relevancerecruitrisk predictionrisk predictionsrisk stratificationscreening toolssenescencesenescentsenior citizensocial health determinantssocio-economicsocio-economic factorssocio-economicallysocioeconomicallysocioeconomicsstratify risksyndemicsynergistic epidemictelomere attritiontranslation researchtranslational investigationtranslational studytuberculosis infectiontuberculous spondyloarthropathyvalidations≥65 years
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

Project Summary / Abstract
This study will investigate the epidemiology, clinical implications, and immunologic and infectious determinants

of aging-related diseases and outcomes in older people with HIV (PWH) in Brazil. In part a result of the long-

term effects of HIV infection and ongoing inflammation, older PWH experience high rates of non-communicable

diseases (NCDs) and early onset of geriatric syndromes including frailty, disability, and cognitive decline.

However, HIV is not alone as a chronic infection that can cause inflammation and other immunological

changes associated with these outcomes. Our knowledge of how other chronic infections endemic to low-and

middle-income countries affect the pathogenesis and epidemiology of geriatric syndromes in is lacking. A

middle-income country with a large population of older PWH, Brazil has a history of comprehensive HIV care

as well as endemic chronic infections. This diverse, longitudinal study will recruit PWH on antiretroviral therapy

≥50 years of age in three Brazilian cities (n=360 ages 50-64years and n=340 ages ≥65 years) to evaluate the

ways coinfections such as TB, HTLV-1, Chagas disease, toxoplasmosis, and others affect the epidemiology

and immunologic pathways of aging-related morbidity. We will examine the association of syndemics of

coinfections and social determinants of health with validated NCDs. We will prospectively evaluate how

individual and cumulative burden of coinfections predict incident geriatric syndromes. We will evaluate a novel

screening tool to assess vulnerability of older PWH for adverse clinical outcomes including death,

hospitalization, and new disability. This study will also investigate how coinfections affect biologic pathways of

inflammation which contribute to development of NDCs and geriatric syndromes Building upon established and

productive collaborations in HIV observational research in Latin America, this study is uniquely positioned to

provide urgently needed, high-quality data to understand aging with HIV in a global context. It will offer novel

insights into a diversity of infectious contributions to cellular mechanisms of aging experienced by PWH around

the globe.

Grant Number: 5R01AG071439-05
NIH Institute/Center: NIH

Principal Investigator: Jessica Castilho

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →